Bone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationTransplantation, AutologousBone MarrowGraft vs Host DiseaseBone Marrow CellsTransplantation ConditioningStem CellsLiver TransplantationPeripheral Blood Stem Cell TransplantationWhole-Body IrradiationTransplantation ChimeraTissue DonorsGraft SurvivalHematopoietic Stem CellsHematologic NeoplasmsLeukemiaBusulfanKidney TransplantationHistocompatibility TestingAnemia, AplasticTreatment OutcomeBone and BonesHistocompatibilityCombined Modality TherapyRecurrenceCyclophosphamideRemission InductionTransplantation, IsogeneicImmunosuppressive AgentsBone Marrow PurgingCord Blood Stem Cell TransplantationRetrospective StudiesTime FactorsMesenchymal Stem Cell TransplantationLeukemia, Myeloid, AcuteCell TransplantationGraft RejectionHeart TransplantationTransplantation ImmunologyHematopoiesisSurvival AnalysisHepatic Veno-Occlusive DiseaseLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAntineoplastic Combined Chemotherapy ProtocolsMultiple MyelomaMice, Inbred C57BLMelphalanSurvival RateCell DifferentiationPrecursor Cell Lymphoblastic Leukemia-LymphomaLung TransplantationGraft vs Leukemia EffectDisease-Free SurvivalBone Marrow DiseasesLymphoma, Non-HodgkinImmunosuppressionMyeloablative AgonistsHLA AntigensLymphocyte DepletionMyelodysplastic SyndromesFollow-Up StudiesHematologic DiseasesAcute DiseaseLymphocyte TransfusionOrgan TransplantationGraft vs Tumor EffectHematopoietic Stem Cell MobilizationLeukemia, MyeloidRadiation ChimeraT-LymphocytesEmbryonic Stem CellsAntigens, CD34Severe Combined ImmunodeficiencyFlow CytometryPrognosisCyclosporineGranulocyte Colony-Stimulating FactorCell ProliferationCytomegalovirus InfectionsCytarabineChimerismEtoposideAdult Stem CellsLeukocyte TransfusionCarmustineCells, CulturedAntineoplastic AgentsBone Marrow ExaminationSalvage TherapyColony-Forming Units AssayGraft vs Host ReactionAntilymphocyte SerumIslets of Langerhans TransplantationTransplantationChimeraHodgkin DiseaseNeoplasms